SCRI

SCRI Impact Report 2023

Issue link: https://uberflip.scri.com/i/1521059

Contents of this Issue

Navigation

Page 7 of 27

The Science of Collaboration Begins with Us Transplant & Cellular Therapy / Complex Hematology Research Sites Drug Development Units Multi-phase Research Sites RGB_SCRI Footprint Map_Version 1.6 Transplant & Cellular Therapy / Complex Hematology Research Sites Drug Development Units Multi-phase Research Sites RGB_SCRI Footprint Map_Version 1.6 Our research network reaches 1 in 5 patients with cancer through our affiliated sites. As a leader in drug development, SCRI has conducted more than 750 first-in-human trials to date. 1,300+ Physicians who are providing access to clinical trials. 4,500+ Registered patients participating in clinical trials annually. 1,000+ Trials actively enrolling patients. 250+ Locations across the U.S. SCRI Network Footprint Transplant & Cellular Therapy / Complex Hematology Research Sites Drug Development Units Multi-phase Research Sites

Articles in this issue

view archives of SCRI - SCRI Impact Report 2023